TY - JOUR
T1 - I-MOVE
T2 - Inpatient pre-discharge mobility score as a predictor of post-discharge mortality
AU - Romero-Brufau, Santiago
AU - Manning, Dennis M.
AU - Borrud, Aleta
AU - Keller, A. Scott
AU - Kashiwagi, Deanne
AU - Cha, Steve
AU - Huddleston, Jeanne M.
AU - Croghan, Ivana
N1 - Funding Information:
This publication was supported by grant number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Publisher Copyright:
Copyright 2016 by Turner White Communications Inc., Wayne, PA. All rights reserved.
PY - 2016/7
Y1 - 2016/7
N2 - • Objective: To determine whether a score of 8 or greater on the I-MOVE, a bedside instrument that evaluates the need for assistance in turning, sitting, standing, transferring from bed to a chair, and ambulating, predicts lower risk for 30-day readmission or mortality. • Design: Retrospective cohort study of patients discharged from 2003 to 2011 from a referral hospital in Southeastern Minnesota. We used a convenience sample of 426 inpatients who had at least one documented calculation of the I-MOVE score performed as part of the clinical process during the study. • Results: Overall 30-day mortality rate, readmission rate, and rate of the combined death/readmission outcome were 6.1% (26 patients), 15% (64 patients) and 19.7% (84 patients), respectively. After controlling for confounding variables, an I-MOVE score ≥ 8 was a significant predictive factor for 30-day mortality (OR = 0.136, P < 0.01) but not 30-day readmission (OR = 1.143, P = 0.62) or the combined outcome death/readmission (OR = 0.682, P = 0.13). • Conclusion: The clinical information provided by a patient's I-MOVE score before discharge does not provide information about readmission risk but may offer incremental information about 30-day mortality risk.
AB - • Objective: To determine whether a score of 8 or greater on the I-MOVE, a bedside instrument that evaluates the need for assistance in turning, sitting, standing, transferring from bed to a chair, and ambulating, predicts lower risk for 30-day readmission or mortality. • Design: Retrospective cohort study of patients discharged from 2003 to 2011 from a referral hospital in Southeastern Minnesota. We used a convenience sample of 426 inpatients who had at least one documented calculation of the I-MOVE score performed as part of the clinical process during the study. • Results: Overall 30-day mortality rate, readmission rate, and rate of the combined death/readmission outcome were 6.1% (26 patients), 15% (64 patients) and 19.7% (84 patients), respectively. After controlling for confounding variables, an I-MOVE score ≥ 8 was a significant predictive factor for 30-day mortality (OR = 0.136, P < 0.01) but not 30-day readmission (OR = 1.143, P = 0.62) or the combined outcome death/readmission (OR = 0.682, P = 0.13). • Conclusion: The clinical information provided by a patient's I-MOVE score before discharge does not provide information about readmission risk but may offer incremental information about 30-day mortality risk.
UR - http://www.scopus.com/inward/record.url?scp=84978434557&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978434557&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84978434557
SN - 1079-6533
VL - 23
SP - 303
EP - 310
JO - Journal of Clinical Outcomes Management
JF - Journal of Clinical Outcomes Management
IS - 7
ER -